Profile image
Story Views

Last Hour:
Last 24 Hours:

CSL Ltd – Product Pipeline Review – 2016 by Market Research Report Store

Wednesday, March 8, 2017 3:27
% of readers think this story is Fact. Add your two cents.

(Before It's News)

MarketResearchReportStore adds “CSL Ltd – Product Pipeline Review – 2016″ latest studies, published in March 2017. It is a professional and in-depth study on the current state.


For a sample of this report, please email at: 




‘CSL Ltd – Product Pipeline Review – 2016’, provides an overview of the CSL Ltd’s pharmaceutical research and development focus.


The report provides comprehensive information on the therapeutics under development by CSL Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.


The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.




- The report provides a snapshot of the pipeline therapeutic landscape of CSL Ltd

- The report provides overview of CSL Ltd including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses CSL Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features CSL Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects


Request Sample Copy, please email at: 


Table Of Contents

CSL Ltd Snapshot 6

CSL Ltd Overview 6

Key Facts 6

CSL Ltd – Research and Development Overview 7

Key Therapeutic Areas 7

CSL Ltd – Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products – Monotherapy 11

Pipeline Products – Combination Treatment Modalities 12

Pipeline Products – Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Pipeline Products – Out-Licensed Products 15

Out-Licensed Products/Combination Treatment Modalities 16

CSL Ltd – Pipeline Products Glance 17

CSL Ltd – Late Stage Pipeline Products 17

Pre-Registration Products/Combination Treatment Modalities 17

Phase III Products/Combination Treatment Modalities 18

CSL Ltd – Clinical Stage Pipeline Products 19

Phase II Products/Combination Treatment Modalities 19

Phase I Products/Combination Treatment Modalities 20

CSL Ltd – Early Stage Pipeline Products 21

Preclinical Products/Combination Treatment Modalities 21

Discovery Products/Combination Treatment Modalities 22

CSL Ltd – Drug Profiles 23

(coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C (human) + protein S (human)) – Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Antibodies for Undisclosed Indication – Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

antihemophilic factor (recombinant), single chain – Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

C1 esterase inhibitor (human) – Drug Profile 28

Product Description 28

Mechanism Of Action 28


Browse Complete Report with TOC @


For report sample or more information, please feel free to contact us:

Shirley | Sales Director

Call: +00-1-626-3463946 - U.S   




About Us

Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.

Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.